Back
Verrica Pharmaceuticals Vs. Innodata Industry Stock Comparison
Sell
19
VRCA
Verrica Pharmaceuticals
Last Price:
$0.54
Seasonality Move:
-18.38%
Buy
51
INOD
Innodata
Last Price:
$48.23
Seasonality Move:
9.95%
Sell
19
Verrica Pharmaceuticals (VRCA)
is a Sell
Is Verrica Pharmaceuticals a Buy, Sell or Hold?
-
The current Verrica Pharmaceuticals [VRCA] share price is $0.59. The Score for VRCA is 19, which is 62% below its historic median score of 50, and infers higher risk than normal.
-
VRCA is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing an extreme reading that indicates risk could be especially high.
VRCA Stock Price Chart
What is Verrica Pharmaceuticals's stock price today?
-
The Verrica Pharmaceuticals share price today is $0.59Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and VRCA is experiencing slight selling pressure.
INOD Stock Price Chart
VRCA Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.03 | Sell |
Relative Strength Index (14 RSI): | 39.23 | Sell |
Chaikin Money Flow: | 0 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (0.61 - 0.71) | Sell |
Bollinger Bands (100): | (0.57 - 1.19) | Sell |
INOD Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.41 | Buy |
Relative Strength Index (14 RSI): | 44.5 | Sell |
Chaikin Money Flow: | -838391 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (42.39 - 56.81) | Sell |
Bollinger Bands (100): | (28.15 - 49.55) | Buy |
VRCA Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 0.62 | Sell |
20-day SMA: | 0.66 | Sell |
50-day SMA: | 0.68 | Sell |
200-day SMA: | 3.04 | Sell |
8-day EMA: | 0.62 | Sell |
20-day EMA: | 0.65 | Sell |
50-day EMA: | 0.74 | Sell |
200-day EMA: | 2.33 | Sell |
INOD Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 47.61 | Sell |
20-day SMA: | 51.75 | Sell |
50-day SMA: | 44 | Sell |
200-day SMA: | 27.42 | Buy |
8-day EMA: | 47.25 | Sell |
20-day EMA: | 48.54 | Sell |
50-day EMA: | 44.99 | Sell |
200-day EMA: | 30.74 | Buy |
Verrica Pharmaceuticals Earnings Growth & VRCA Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.30 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.02 per share, and an increase next year of $0.04 per share.
Innodata Earnings Growth & INOD Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.01 per share, an increase next quarter of $0.06 per share, a decrease this year of $0.03 per share, and an increase next year of $0.36 per share.
Verrica Pharmaceuticals Technical Analysis
Feb 27 | Feb 28 | Mar 3 | Mar 4 | Mar 5 | Mar 6 | Mar 7 | Mar 11 | Mar 12 | Mar 13 | |
---|---|---|---|---|---|---|---|---|---|---|
Feb | Mar | |||||||||
27 | 28 | 03 | 04 | 05 | 06 | 07 | 11 | 12 | 13 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Innodata Technical Analysis
Feb 27 | Feb 28 | Mar 3 | Mar 4 | Mar 5 | Mar 6 | Mar 7 | Mar 11 | Mar 12 | Mar 13 | |
---|---|---|---|---|---|---|---|---|---|---|
Feb | Mar | |||||||||
27 | 28 | 03 | 04 | 05 | 06 | 07 | 11 | 12 | 13 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |